Cargando…

MYH9 is crucial for stem cell-like properties in non-small cell lung cancer by activating mTOR signaling

The fatality rate of non-small cell lung cancer (NSCLC) has been high due to the existence of cancer stem cells (CSCs). Non-muscle myosin heavy chain 9 (MYH9) can promote the progression of various tumors, but its effect on the stem cell-like characteristics of lung cancer cells (LCCs) has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Meng, Sun, Li-Xin, Yu, Long, Liu, Jun, Sun, Li-Chao, Yang, Zhi-Hua, Shu, Xiong, Ran, Yu-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505404/ https://www.ncbi.nlm.nih.gov/pubmed/34635641 http://dx.doi.org/10.1038/s41420-021-00681-z

Ejemplares similares

Inhibition of mTOR or MAPK ameliorates vmhcl/myh7 cardiomyopathy in zebrafish
por: Bu, Haisong, et al.
Publicado: (2021)

BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer
por: Shu, Xiong, et al.
Publicado: (2021)

MYH9 nephropathy
por: Oh, Taehoon, et al.
Publicado: (2015)

NAP1L5 targeting combined with MYH9 Inhibit HCC progression through PI3K/AKT/mTOR signaling pathway
por: Zhao, Rui, et al.
Publicado: (2022)

The Prognostic Role of mTOR and P-mTOR for Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Li, Lei, et al.
Publicado: (2015)

Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway
por: Shu, Xiong, et al.
Publicado: (2021)

Identification of MYH9 Key Domain Involved in the Entry of PRRSV Into Permissive Cells
por: Li, Liangliang, et al.
Publicado: (2022)

Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer
por: Katono, Ken, et al.
Publicado: (2015)

Targeting mTOR to Overcome Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cells
por: Fei, Shi-Jiang, et al.
Publicado: (2013)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines
por: Panza, Emanuele, et al.
Publicado: (2008)

Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney
por: Otterpohl, Karla L., et al.
Publicado: (2017)

ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis
por: Liu, Jiahao, et al.
Publicado: (2022)

Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
por: Yu, Mengxia, et al.
Publicado: (2016)

Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis
por: Yang, Ting, et al.
Publicado: (2020)

Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
por: Li, Yuhong, et al.
Publicado: (2020)

CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis
por: Yu, Shi-Tong, et al.
Publicado: (2020)

A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature
por: Ai, Qi, et al.
Publicado: (2020)

Neuroprotective Strategy in Retinal Degeneration: Suppressing ER Stress-Induced Cell Death via Inhibition of the mTOR Signal
por: Fan, Bin, et al.
Publicado: (2017)

The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620
por: Zha, Jian-hua, et al.
Publicado: (2021)

mTOR sends T cells on their way
por: LeBrasseur, Nicole
Publicado: (2008)

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
por: Scholz, Godehard, et al.
Publicado: (2016)

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
por: Milella, Michele, et al.
Publicado: (2017)

Exploratory Analysis of Selected Components of the mTOR Pathway Reveals Potentially Crucial Associations with Childhood Malnutrition
por: Palit, Parag, et al.
Publicado: (2022)

Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
por: Lin, Shao Jian, et al.
Publicado: (2015)

The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
por: Qiu, Weiwei, et al.
Publicado: (2022)

TTI1 promotes non‐small‐cell lung cancer progression by regulating the mTOR signaling pathway
por: Zhang, Ling‐Xian, et al.
Publicado: (2022)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

MYH9 facilitates autoregulation of adipose tissue depot development
por: Cheung, Sin Ying, et al.
Publicado: (2021)

Transcriptional Regulation of NK Cell Development by mTOR Complexes
por: Yang, Chao, et al.
Publicado: (2020)

Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease
por: Otterpohl, Karla L., et al.
Publicado: (2020)

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer
por: Schmid, K, et al.
Publicado: (2010)

DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway
por: Luo, Jing, et al.
Publicado: (2020)

Resveratrol Induces Autophagy and Apoptosis in Non-Small-Cell Lung Cancer Cells by Activating the NGFR-AMPK-mTOR Pathway
por: Li, Jiaqiao, et al.
Publicado: (2022)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

mTOR Signaling Network in Cell Biology and Human Disease
por: Yu, Jane J., et al.
Publicado: (2022)

The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
por: Liu, Chunhua, et al.
Publicado: (2021)

Palladin promotes cancer stem cell‐like properties in lung cancer by activating Wnt/Β‐Catenin signaling
por: Shu, Xiong, et al.
Publicado: (2022)

SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin Signaling
por: Li, Qing, et al.
Publicado: (2023)

Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
por: Lyu, Jing-Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cqhh3mskuhb11jac8m4qbk7ujh